Scholar Rock Holding SRRK
NASDAQ SRRK
$55.47 -0.47 (-0.85%)
As of: Sep 4, 2026 · 2:38 PM EDT

Scholar Rock Holding (SRRK) Change in Acquisitions & Divestments (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Change in Acquisitions & Divestments of $20.0 million for Q1 2026, down 78.47% year-over-year from $92.9 million in Q1 2025, and down 48.72% quarter-over-quarter from $39.0 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Change in Acquisitions & Divestments (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $20.0 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 78.47% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $244.4 million (up 1.12% YoY), while the FY2025 annual figure was $317.3 million, up 46.09% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $20.0 million, down from $39.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $106.9 million in Q2 2025, with the low at $10.0 million in Q1 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $68.4 million (2024), against an average of $59.8 million.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments tumbled 81.82% in 2022, then jumped 800.0% in 2023.
  • Scholar Rock Holding's Change in Acquisitions & Divestments stood at $10.0 million in 2022, then surged by 690.0% to $79.0 million in 2023, then tumbled by 80.89% to $15.1 million in 2024, then surged by 158.28% to $39.0 million in 2025, then tumbled by 48.72% to $20.0 million in 2026.
  • Business Quant data shows SRRK's Change in Acquisitions & Divestments at $20.0 million in Q1 2026, $39.0 million in Q4 2025, and $78.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn -
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Scholar Rock Holding 7.24 Bn 7.24 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.50 Mn
Mar 31, 2026 20.00 Mn
Dec 31, 2025 39.00 Mn
Sep 30, 2025 78.50 Mn
Jun 30, 2025 106.90 Mn
Mar 31, 2025 92.90 Mn
Dec 31, 2024 15.10 Mn
Sep 30, 2024 49.60 Mn
Jun 30, 2024 84.10 Mn
Mar 31, 2024 68.40 Mn
Dec 31, 2023 79.00 Mn
Sep 30, 2023 73.00 Mn
Jun 30, 2023 90.00 Mn
Mar 31, 2023 90.00 Mn
Dec 31, 2022 10.00 Mn
Sep 30, 2022 65.00 Mn
Jun 30, 2022 45.00 Mn
Mar 31, 2022 10.00 Mn
Dec 31, 2021 30.00 Mn
Sep 30, 2021 35.00 Mn